What are appropriate management options for insomnia when I cannot fall asleep, not due to racing thoughts, despite taking two doses of diphenhydramine (Benadryl)?

Management of Insomnia Unresponsive to Diphenhydramine

Stop using diphenhydramine (Benadryl) for your insomnia—it lacks evidence for effectiveness and you should instead pursue cognitive behavioral therapy for insomnia (CBT-I) as first-line treatment. 1

Why Diphenhydramine Isn't Working

• Diphenhydramine has not been adequately studied for insomnia treatment, and the American College of Physicians specifically notes that "commonly used older and generic medications, such as diphenhydramine and trazodone, have not been studied" in their systematic review of insomnia treatments. 1

• The FDA label for Benadryl explicitly warns "do not use to make a child sleepy" and cautions about marked drowsiness, excitability (especially in children), and the need to avoid use with other diphenhydramine-containing products. 2

• While one recent expert consensus suggests diphenhydramine may be effective for acute insomnia only (not chronic), the evidence remains limited and it should not be used beyond short-term treatment. 3

First-Line Treatment: Cognitive Behavioral Therapy for Insomnia (CBT-I)

The American College of Physicians and VA/DoD guidelines both strongly recommend CBT-I as initial treatment for all adults with chronic insomnia disorder. 1

What CBT-I Includes:

• Sleep restriction therapy: Limiting time in bed to match actual sleep time, then gradually increasing it 1
• Stimulus control: Using the bed only for sleep and sex, leaving the bedroom if unable to sleep within 15-20 minutes 1
• Cognitive therapy: Addressing negative thoughts and anxiety about sleep 1
• Sleep hygiene education: Though not effective alone, it's part of comprehensive CBT-I 1

Delivery Options for CBT-I:

• In-person individual or group therapy 1
• Telephone-based or web-based modules 1
• Self-help books 1

Why CBT-I Is Superior:

• CBT-I shows equivalent short-term results (2-4 weeks) to medications but superior long-term outcomes 1
• Moderate-quality evidence demonstrates improved sleep efficiency, reduced sleep onset latency, reduced wake after sleep onset, and improved sleep quality 1
• Minimal harms compared to pharmacotherapy—only transient sleepiness during initial sleep restriction that resolves quickly 1

If CBT-I Fails: Pharmacologic Options

Only consider medications after CBT-I has been unsuccessful, using shared decision-making to discuss benefits, harms, and costs of SHORT-TERM use. 1

Evidence-Based Medication Options (in order of preference):

For Sleep Onset Insomnia:

• Low-dose doxepin (3 or 6 mg): Improves sleep onset latency and total sleep time with no significant difference in adverse events compared to placebo in clinical trials 1
• Ramelteon: Melatonin receptor agonist, safer profile but limited effectiveness 4, 5
• Zolpidem or zaleplon (Z-drugs): Short-acting options for sleep onset 1, 5

For Sleep Maintenance Insomnia:

• Suvorexant (dual orexin receptor antagonist): Moderate-quality evidence for improved treatment response and sleep outcomes 1, 5
• Low-dose doxepin: Also effective for sleep maintenance 1, 5
• Eszopiclone: Can address both sleep onset and maintenance 5

Critical Warnings About Medications:

• Benzodiazepines should be avoided due to risks of dementia, fractures, cognitive impairment, and withdrawal phenomena 1

• The FDA warns about serious injuries from sleep behaviors (sleepwalking, sleep driving) with nonbenzodiazepine BZRAs, requiring use at lowest effective dose for shortest duration 1

• All hypnotics carry risks of daytime impairment, motor vehicle accidents, and behavioral changes, with the FDA recommending lower doses in women and older adults 1

• Long-term safety data for pharmacologic treatments is lacking, raising concerns about extended use 1

What NOT to Do

• Do not continue diphenhydramine—routine use of over-the-counter antihistamines should be discouraged 6
• Do not use alcohol as a sleep aid—it has potential for abuse 6
• Do not use trazodone routinely—it's commonly used off-label but carries significant risks and lacks adequate evidence 5
• Avoid benzodiazepines unless absolutely necessary and only for very short-term use 1

Practical Next Steps

1. Discontinue diphenhydramine immediately—no tapering needed for antihistamines 7

2. Seek CBT-I through any available modality (even web-based or self-help if in-person unavailable) 1

3. If symptoms are severe and CBT-I is not immediately accessible, consider a short course (4-5 weeks maximum) of low-dose doxepin (3-6 mg) or a Z-drug while arranging CBT-I 1

4. Ensure you're not dealing with another sleep disorder (sleep apnea, restless legs syndrome) or underlying medical/psychiatric condition that requires specific treatment 1